Ultragenyx Pharma (RARE) PT Raised to $178 at SVB Leerink on 2021 Opportunities
Tweet Send to a Friend
SVB Leerink analyst Joseph Schwartz raised the price target on Ultragenyx Pharma (NASDAQ: RARE) to $178.00 (from $115.00) after the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
